July 23, 2024 — Nearly 40 million adults in the U.S. have sleep apnea ... 2024 — A new study demonstrates that when individuals with obstructive sleep apnea use their positive airway pressure ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to be ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

According to drugmaker Eli Lilly, it’s the first and only FDA-approved prescription medication for adults with obstructive sleep apnea. It’s also FDA-approved to treat obesity. Obstructive ...

Obstructive sleep apnea (OSA) occurs when any part of the airway from the tip of the nose to the lungs collapses during sleep and disrupts breathing. As such, it is often due to a person’s underlying ...

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...